COVID-19

Development of COVID-19 vaccine

Dengue

Development of nanoparticle-based dengue DNA vaccine

HIV

We have been working on HIV DNA vaccine

HDM Allergy

Development of vaccines for prevention and treatment of HDM allergy

Leptospirosis

Development of subunit vaccines against leptospirosis

Center of Excellence in Vaccine Research and Development,
Chulalongkorn University (Chula VRC)

Chula VRC was formally established in 2017 under the supervision of Professor Kiat Ruxrungtham. We consists of faculty staff and researchers with common interest in vaccine research and development to work together and share their knowledge and experience leading to the strength of the team. We focuses not only on vaccines against infectious diseases, such as HIV infection, dengue fever, leptospirosis, and emerging infections including novel corona virus disease (COVID-19) but also vaccines against non-infectious diseases including house dust mite allergy.


We are Chula VRC

Dengue Team

HIV Team

House Dust Mite Team

Leptospirosis Team

COVID-19 Team

Key Contact Persons

Latest News & Events

August 30, 2021
Amid a global shortage of vaccines and a new wave of COVID-19 infections, some countries in Southeast Asia are rushing to develop their own coronavirus shots.
Posted in News | Tags: , ,
August 17, 2021

COVID19 Vaccine Tracker – Chulalongkorn University: ChulaCov19

Posted in News | Tags: , ,
August 17, 2021

The research team behind the development of a local mRNA Covid-19 vaccine on Monday asked the government to help finance the project

Posted in News | Tags: , ,
August 16, 2021

The mRNA vaccine, currently being developed by the Vaccine Research Centre of the Faculty of Medicine of Chulalongkorn University, can stimulate the immune system to produce killer T-cells

Posted in News | Tags: , ,
August 16, 2021

The Phase 1 trial of Thailand’s homegrown mRNA COVID-19 vaccine ChulaCOV-19, suggests the candidate vaccine can help the body elicit

Posted in News | Tags: , ,
August 5, 2021

The Faculty of Medicine at Bangkok’s Chulalongkorn University has put out a call for healthy volunteers to take part in trials of its Covid-19 mRNA vaccine.

Posted in News | Tags: , ,
August 3, 2021

TriLink enables Chula VRC to take its Covid-19 vaccine into a First in Human (FIH) phase 1 clinical trial in Thailand with mRNA

Posted in News | Tags: , ,
July 29, 2021

With Covid-19 battering Thailand and the third wave bringing the Sinovac-resistant Delta variant to the forefront of the pandemic,

Posted in News | Tags: , ,
July 25, 2021

This episode talks about the procedures of vaccine invention and manufacturing and about the new technology of mRNA